The Lancet Respiratory Medicine: First UK Biobank genetic study reveals new associations with lung disease and smoking behavior

September 27, 2015

New research published in The Lancet Respiratory Medicine and presented at this year's European Respiratory Society (ERS) meeting in Amsterdam presents the first analyses of genetic data from the UK Biobank [1] that reveal new associations with lung disease and smoking behaviour. The study is by Prof Ian Hall, Queen's Medical Centre, University of Nottingham, UK, and Prof Martin Tobin, University of Leicester, UK, and colleagues.

Chronic obstructive pulmonary disease (COPD) is a global public health concern and is currently the third leading cause of death worldwide. Understanding the genetic basis of airflow obstruction and smoking behaviour is key to determining the mechanisms which cause COPD. In this study, the UK Biobank Lung Exome Variant Evaluation (UK BiLEVE) [2], the authors generated extensive new genetic data in the UK Biobank to investigate the genetic causes of smoking behaviour and lung health.

The study sampled individuals from the UK Biobank with the best, average or the poorest lung function among heavy smokers and never smokers. Using a new genotyping array, which measures over 800,000 genetic variants in each UK Biobank participant, and new methods of analysis of genetic data, they were able to compare lung health and smoking behaviour with both common and rare genetic variations across the whole human genome.

The team discovered six independent genetic variants associated with lung health and COPD. They also found genetic variants associated with COPD in people who have never smoked. One of these new signals is the first example of structural variation of the human genome affecting lung health. The team found that the numbers of copies of duplicated sequence of the genome on Chromosome 17 was associated with lung health in heavy smokers and also in never smokers. This, and other findings in the study, point to possible widespread effects on gene regulation and, in turn, protein production. Importantly for the prevention of COPD and other smoking-related diseases, five independent genetic variants were discovered which were associated with heavy smoking.

The authors say, "These findings, taken together with previous findings, will help define pathways underlying predisposition to development of COPD and smoking behaviours. A full understanding of the biological mechanisms underlying these genetic associations will improve our understanding of the pathophysiology of COPD and smoking behaviour, and potentially give rise to novel therapeutic strategies for the management of airway disease and prevention of nicotine addiction."

They add, "We especially wish to thank all the UK Biobank participants, whose willingness to contribute to the study has made these scientific discoveries possible. The research was also made possible by many years of preparatory work by the UK Biobank team and by the support of the Medical Research Council. We now look forward to hearing the findings from new studies underway that utilise the genetic data generated by the UK BiLEVE study. Ultimately, we would like to see improved prevention and treatment of lung disease and these discoveries are important steps towards this ambitious goal." [3]

In a linked Comment, Professor Guy Brusselle, Ghent University Hospital, Ghent, Belgium, and Erasmus Medical Center, Rotterdam, the Netherlands, and Dr Ken Bracke, Ghent University Hospital, Ghent , Belgium, say: "We are looking forward to new genetic studies in the UK Biobank investigating other lung function measurements, and other hallmarks of COPD such as chronic bronchitis and emphysema. Thanks to the vast number of participants, the optimal genotyping arrays, and the smart study designs in the UK Biobank, the future looks bright for unravelling the genetic cause of COPD."

This study was funded by the Medical Research Council.

[1] The UK Biobank is a long term study investigating the respective contributions of genetic predisposition and environmental exposure (including nutrition, lifestyle, medications etc.) to the development of disease. It began in 2007.

[2] The UK BiLEVE (UK Biobank Lung Exome Evaluation) study generated genetic data and used lung health measurements from the UK Biobank to study common and rare genetic variants in respiratory health.

[3] Quote direct from Author and cannot be found in text of Article.

The Lancet

Related Smoking Articles from Brightsurf:

Smoking rates falling in adults, but stroke survivors' smoking rates remain steady
While the rate of Americans who smoke tobacco has fallen steadily over the last two decades, the rate of stroke survivors who smoke has not changed significantly.

What is your risk from smoking? Your network knows!
A new study from researchers at Penn's Annenberg School for Communication found that most people, smokers and non-smokers alike, were nowhere near accurate in their answers to questions about smoking's health effects.

Want to quit smoking? Partner up
Kicking the habit works best in pairs. That's the main message of a study presented today at EuroPrevent 2019, a scientific congress of the European Society of Cardiology (ESC).

Smoking and mortality in Asia
In this analysis of data from 20 studies conducted in China, Japan, South Korea, Singapore, Taiwan and India with more than 1 million participants, deaths associated with smoking continued to increase among men in Asia grouped by the years in which they were born.

Predictors of successfully quitting smoking among smokers registered at the quit smoking clinic at a public hospital in northeastern Malaysia
In the current issue of Family Medicine and Community Health, Nur Izzati Mohammad et al. consider how cigarette smoking is one of the risk factors leading to noncommunicable diseases such as cardiovascular and respiratory system diseases and cancer.

Restaurant and bar smoking bans do reduce smoking, especially among the highly educated
Smoking risk drops significantly in college graduates when they live near areas that have completely banned smoking in bars and restaurants, according to a new study in the American Journal of Epidemiology.

How the UK smoking ban increased wellbeing
Married women with children reported the largest increase in well-being following the smoking bans in the UK in 2006 and 2007 but there was no comparable increase for married men with children.

Smoking study personalizes treatment
A simple blood test is allowing Vanderbilt University Medical Center (VUMC) researchers to determine which patients should be prescribed varenicline (Chantix) to stop smoking and which patients could do just as well, and avoid side effects, by using a nicotine patch.

A biophysical smoking gun
While much about Alzheimer's disease remains a mystery, scientists do know that part of the disease's progression involves a normal protein called tau, aggregating to form ropelike inclusions within brain cells that eventually strangle the neurons.

A case where smoking helped
A mutation in the hemoglobin of a young woman in Germany was found to cause her mild anemia.

Read More: Smoking News and Smoking Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to